{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:51:41Z","timestamp":1793389901669,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.semarthrit.2024.152439","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:43:24Z","timestamp":1711475004000},"page":"152439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the \u201cCAPS registry\u201d"],"prefix":"10.1016","volume":"66","author":[{"given":"Isaac","family":"Pons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Jer\u00e9z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1336-0163","authenticated-orcid":false,"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/j.semarthrit.2024.152439_bib0001","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/S0049-3848(17)30066-X","article-title":"Antiphospholipid syndrome","volume":"151","author":"Cervera","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0002","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"ACR\/EULAR APS classification criteria collaborators. 2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0003","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1002\/art.10187","article-title":"Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients","volume":"46","author":"Cervera","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0004","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1136\/annrheumdis-2013-204838","article-title":"Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients","volume":"74","author":"Cervera","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0006","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.autrev.2006.06.005","article-title":"The catastrophic antiphospholipid (Asherson's) syndrome","volume":"6","author":"Asherson","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0007","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"Rodr\u00edguez-Pint\u00f3","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102908","article-title":"Prevalence, characteristics and outcome of cardiac manifestations in critically-ill antiphospholipid syndrome patients","volume":"133","author":"Azoulay","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0009","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0010","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Catastrophic antiphospholipid syndrome registry project group. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0011","volume":"1","author":"Bozkurt","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0012","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth universal definition of myocardial infarction (2018)","volume":"72","author":"Thygesen","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0013","series-title":"StatPearls [Internet]","article-title":"Libman-sacks endocarditis","author":"Ibrahim","year":"2023"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0002-9343(94)90108-2","article-title":"Comparison of the primary and secondary antiphospholipid syndrome: a European Multicenter Study of 114 patients","volume":"96","author":"Vianna","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0015","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000174866","article-title":"Anticardiolipin antibody and stroke: possible relation of valvular heart disease and embolic events","volume":"79","author":"Barbut","year":"1991","journal-title":"Cardiology"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0016","first-page":"357","article-title":"Sneddon's syndrome: cardiac pathology and antiphospholipid antibodies","volume":"9","author":"Kalashnikova","year":"1991","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0017","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/rheumatology\/30.4.305","article-title":"Non-infective verrucous endocarditis in a patient with \u2018primary\u2019 antiphospholipid syndrome","volume":"30","author":"Font","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0018","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0735-1097(91)90749-Y","article-title":"Cardiac involvement in patients with primary antiphospholipid syndrome","volume":"18","author":"Brenner","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/096120339100100108","article-title":"High prevalence of significant heart valve lesions in patients with the \u2018primary\u2019 antiphospholipid syndrome","volume":"1","author":"Cervera","year":"1991","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0020","doi-asserted-by":"crossref","first-page":"293","DOI":"10.7326\/0003-4819-116-4-293","article-title":"Valvular heart disease in the primary antiphospholipid syndrome","volume":"116","author":"Galve","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0021","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0961203309353772","article-title":"Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients","volume":"19","author":"Pardos-Gea","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0022","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ard.2004.032813","article-title":"Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome","volume":"64","author":"Krause","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0023","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/jcm12082996","article-title":"Heart valve involvement in patients with antiphospholipid syndrome: a long-term follow-up study of a single centre","volume":"12","author":"Pons","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0024","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.21162","article-title":"Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study","volume":"53","author":"Perez-Villa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0025","doi-asserted-by":"crossref","first-page":"729","DOI":"10.17219\/acem\/27570","article-title":"IgA antiphospholipid antibodies and anti-domain 1 of beta 2 glycoprotein 1 antibodies are associated with livedo reticularis and heart valve disease in antiphospholipid syndrome","volume":"23","author":"Cie\u015bla","year":"2014","journal-title":"Adv Clin Exp Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152439_bib0026","first-page":"162","article-title":"Association between cardiac manifestations and antiphospholipid antibody type and level in a cohort of Serbian patients with primary and secondary antiphospholipid syndrome","volume":"16","author":"Djokovic","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0027","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/CIRCULATIONAHA.111.028522","article-title":"Increased risk for heart valve disease associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: meta-analysis of echocardiographic studies","volume":"124","author":"Zuily","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0028","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2005.04.022","article-title":"Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome","volume":"96","author":"Turiel","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0029","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.autrev.2016.09.007","article-title":"Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus","volume":"15","author":"Vivero","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0002-8703(99)70424-2","article-title":"Echocardiographic evaluation of patients with primary antiphospholipid syndrome","volume":"137","author":"Esp\u00ednola-Zavaleta","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0031","first-page":"2402","article-title":"Primary antiphospholipid syndrome: a 5-year transesophageal echocardiographic followup study","volume":"31","author":"Zavaleta","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0032","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.semarthrit.2013.07.016","article-title":"Evolution of cardiac dysfunction in patients with antiphospholipid antibodies and\/or antiphospholipid syndrome: a 10-year follow-up study","volume":"43","author":"Kampolis","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0033","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1177\/09612033211002273","article-title":"Catastrophic antiphospholipid syndrome presented as ruptured papillary muscle during puerperium in a patient with systemic lupus erythematosus","volume":"30","author":"Rato","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0034","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1159\/000516572","article-title":"Neovascular glaucoma as a presenting sign of catastrophic antiphospholipid syndrome with a \u201ccatastrophic\u201d heart valve finding","volume":"12","author":"Grinberg","year":"2021","journal-title":"Case Rep Ophthalmol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0035","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jcin.2019.08.007","article-title":"MitraClip detachment and recapture in a patient with catastrophic antiphospholipid syndrome","volume":"12","author":"Millan-Iturbe","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0036","first-page":"215","article-title":"Reversible cardiac valvular disease in catastrophic antiphospholipid syndrome","volume":"68","author":"Teunisse","year":"2010","journal-title":"Neth J Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0037","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2796.2000.00762.x","article-title":"A role for transoesophageal echocardiography in the early diagnosis of catastrophic antiphospholipid syndrome","volume":"248","author":"Zakynthinos","year":"2000","journal-title":"J Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0038","doi-asserted-by":"crossref","first-page":"e531","DOI":"10.1161\/CIRCULATIONAHA.107.726943","article-title":"Images in cardiovascular medicine. Numerous small vegetations revealing Libman-Sacks endocarditis in catastrophic antiphospholipid syndrome","volume":"116","author":"Yamamoto","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0039","first-page":"e42012","article-title":"Catastrophic antiphospholipid syndrome: a rare cause of acute heart failure","volume":"15","author":"Elmusa","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0040","doi-asserted-by":"crossref","first-page":"ytac199","DOI":"10.1093\/ehjcr\/ytac199","article-title":"Cardiovascular complications of catastrophic antiphospholipid syndrome: a case report and review of literature","volume":"6","author":"Mittal","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0041","doi-asserted-by":"crossref","first-page":"ytac446","DOI":"10.1093\/ehjcr\/ytac446","article-title":"A case report of acute heart failure and cardiogenic shock caused by catastrophic antiphospholipid syndrome and lupus myocarditis","volume":"6","author":"Lai","year":"2022","journal-title":"Eur Heart J Case Rep"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0042","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jha2.71","article-title":"I. Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: a case series and review","volume":"1","author":"Hermel","year":"2020","journal-title":"EJHaem"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0043","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1177\/0961203319871099","article-title":"Systemic lupus and catastrophic antiphospholipid syndrome manifesting as cardiogenic shock","volume":"28","author":"Schultz","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0044","doi-asserted-by":"crossref","first-page":"48","DOI":"10.14503\/THIJ-17-6472","article-title":"Catastrophic antiphospholipid syndrome presenting as congestive heart failure in a patient with thrombotic microangiopathy","volume":"46","author":"Tulai","year":"2019","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0045","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1177\/0961203315587960","article-title":"A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRI","volume":"24","author":"Rosenbaum","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0046","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.ijcard.2006.08.083","article-title":"Catastrophic antiphospholipid syndrome with heart involvement: diagnostic utility of the cardiac MRI","volume":"116","author":"Plastiras","year":"2007","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0047","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1097\/RHU.0000000000001253","article-title":"Massive right ventricular thrombus secondary to catastrophic antiphospholipid syndrome","volume":"27","author":"Alhassan","year":"2021","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0048","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/VHRM.S197638","article-title":"Intracardiac thrombus in a patient with catastrophic antiphospholipid syndrome: an autopsy case report and review of the literature","volume":"15","author":"Waisayarat","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0049","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1164\/rccm.201901-0030IM","article-title":"Simultaneous left and right ventricular thrombi caused by catastrophic antiphospholipid syndrome","volume":"200","author":"Akdime","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajem.2013.09.032","article-title":"Acute left main coronary artery thrombosis as the first manifestation of systemic lupus erythematosus and catastrophic antiphospholipid syndrome","volume":"32","author":"Gonz\u00e1lez-Pacheco","year":"2014","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0051","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jclinane.2010.07.007","article-title":"Devastating intracardiac and aortic thrombosis: a case report of apparent catastrophic antiphospholipid syndrome during liver transplantation","volume":"23","author":"Gologorsky","year":"2011","journal-title":"J Clin Anesth"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0052","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-225495","article-title":"Catastrophic antiphospholipid syndrome causing ST-segment elevation myocardial infarction with non-obstructive coronary arteries","volume":"12","author":"Cranley","year":"2019","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0053","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2169\/internalmedicine.4123-19","article-title":"Sudden Cardiac Arrest as the First Manifestation in a Patient with Catastrophic Antiphospholipid Syndrome","volume":"59","author":"Sahashi","year":"2020","journal-title":"Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0054","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/heartjnl-2021-319603","article-title":"Inflammatory and thrombotic valvulopathies in autoimmune disease","volume":"109","author":"Gartshteyn","year":"2023","journal-title":"Heart"},{"issue":"3","key":"10.1016\/j.semarthrit.2024.152439_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102990","article-title":"Myocardial involvement in anti-phospholipid syndrome: beyond acute myocardial infarction","volume":"21","author":"Coletto","year":"2022","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.semarthrit.2024.152439_bib0056","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.3390\/jcm12082996","article-title":"Heart valve involvement in patients with antiphospholipid syndrome: a long-term follow-up study of a single centre","volume":"20","author":"Pons","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0057","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/0961203309353772","article-title":"Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients","volume":"19","author":"Pardos-Gea","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2024.152439_bib0058","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ard.2004.032813","article-title":"Close association between valvar heart disease and central nervous system manifestations in the antiphospholipid syndrome","volume":"64","author":"Krause","year":"2005","journal-title":"Ann. Rheum. Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2024.152439_bib0059","doi-asserted-by":"crossref","first-page":"844","DOI":"10.3390\/biomedicines9070844","article-title":"Diagnostic challenges on the laboratory detection of lupus anticoagulant","volume":"9","author":"Tripodi","year":"2021","journal-title":"Biomedicines"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224000799?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224000799?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T01:47:43Z","timestamp":1718416063000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224000799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":59,"alternative-id":["S0049017224000799"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152439","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac involvement in the catastrophic antiphospholipid syndrome (CAPS): Lessons from the \u201cCAPS registry\u201d","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152439"}}